Drew L. Lambert
Papers
1
Total Citations
11
H-Index
1
About
Drew L. Lambert is a researcher whose work bridges clinical oncology and health economics, with a primary focus on optimizing treatment strategies for small renal masses. His most cited study, a 2022 cost-effectiveness analysis comparing percutaneous microwave ablation to robotic-assisted partial nephrectomy, has garnered 11 citations and represents a key contribution to evidence-based urologic oncology. This work systematically evaluates the trade-offs between minimally invasive thermal ablation and surgical resection, providing critical data to guide clinical decision-making and resource allocation. Lambert’s research demonstrates a commitment to quantifying the real-world value of emerging technologies, particularly in the context of localized kidney cancer where treatment choices significantly impact patient outcomes and healthcare costs. By integrating rigorous economic modeling with clinical outcomes, his analysis offers a framework for balancing efficacy, safety, and affordability—a pressing concern in modern oncology. While his citation count reflects a developing career, the practical implications of his work resonate with surgeons, interventional radiologists, and policymakers seeking to refine treatment algorithms. Lambert’s contributions highlight the growing importance of health technology assessment in personalized cancer care, positioning him as a thoughtful voice in the dialogue between innovation and sustainability.
Research Focus
Key Achievements
Top Papers
- 1